A cytotoxic CD40/p55 tumor necrosis factor receptor hybrid detects CD40 ligand on herpesvirus saimiri‐transformed T cells
- 1 January 1995
- journal article
- Published by Wiley in European Journal of Immunology
- Vol. 25 (1) , 80-86
- https://doi.org/10.1002/eji.1830250116
Abstract
The B cell activation molecule CD40 and the p55 tumor necrosis factor receptor (p55TNFR) belong to the same family of structurally conserved proteins. We constructed a chimeric receptor consisting of the CD40 extracellular and transmembrane domains and the p55TNFR intracellular domain. This receptor hybrid retained the biological activity and the ligand specificity of the respective wild‐type receptor domains. Thus it exerted a marked cytotoxic effect in three different transfected cell lines after activation not only with anti‐CD40 antibody but also with CD40 ligand (CD40L) in soluble and membrane‐bound forms. Using hybrid‐transfected baby hamster kidney cells we demonstrated that herpesvirus saimiri‐transformed human CD4+ T lymphocytes constitutively express bioactive CD40 ligand on their surface. The hybrid receptor‐based assay was highly specific for CD40 activating reagents and more sensitive than an assay measuring CD40‐mediated B cell rescue from apoptosis. Hence CD40/p55TNFR transfectants may be useful for dissecting CD40L‐mediated events in T‐B cell interactions, and also to detect a defective CD40L molecule in putative hyper‐IgM syndrome patients.Keywords
This publication has 67 references indexed in Scilit:
- Unraveling Function in the TNF Ligand and Receptor FamiliesScience, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- CD40 ligand is a T cell growth factorEuropean Journal of Immunology, 1993
- A novel domain within the 55 kd TNF receptor signals cell deathCell, 1993
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993
- Identification of a source of biologically active CD40 ligandEuropean Journal of Immunology, 1992
- Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosisNature, 1991
- Molecular cloning and expression of the human 55 kd tumor necrosis factor receptorCell, 1990
- Synergistic interaction between interleukin 4 and anti-Bp50 (CDw40) revealed in a novel B cell restimulation assayEuropean Journal of Immunology, 1987
- Dye Uptake Methods for Assessing Viral Cytopathogenicity and their Application to Interferon AssaysJournal of General Virology, 1969